Health
Healthcare
Biotechnology

IQVIA Holdings

$134.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.38 (-0.28%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell IQVIA Holdings and other stocks, options, ETFs, and crypto commission-free!

About

IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. Read More The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Employees
58,000
Headquarters
Durham, North Carolina
Founded
1982
Market Cap
26.59B
Price-Earnings Ratio
111.51
Dividend Yield
0.00
Average Volume
1.31M
High Today
$134.44
Low Today
$132.18
Open Price
$133.63
Volume
495.93K
52 Week High
$146.10
52 Week Low
$97.65

Collections

Health
Healthcare
Biotechnology
Professional Services
Information Technology
Technology
Pharmaceutical
Business Services

News

Yahoo FinanceMay 13

IQVIA Launches IQVIA MedTech Dedicated to Medical Device and Diagnostics Industry

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA MedTech provides innovative technology, focused solutions and consulting services to meet the industry-specific needs of this life sciences segment from concept-to-market IQVIA™ (IQV) today announced the launch of IQVIA MedTech and its dedicated industry focused solutions and services for the medical device and in vitro diagnostics market, and for companies with combination products. IQVIA MedTech empowers companies to orchestrate oper...

40
Associated PressMay 7

IQVIA Announces Pricing of Offering of Senior Notes

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--May 7, 2019--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,100,000,000 in aggregate principal amount of senior notes due 2027 (the “notes”). The net proceeds from the notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility, to pay fees and expenses related to the notes offering and for other general cor...

14
Markets InsiderMay 7

United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives

HENDERSON, Nev., May 07, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that IQVIA has completed its independent market assessment of certain market opportunities for HemoStyp. This survey used a combination of interviews, market data and product usage reports to create a detailed outlook for HemoStyp’s revenue potential assuming, among o...

26

Earnings

$1.14
$1.27
$1.40
$1.53
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 23, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.